Epidemiology of TNBC in Asyut Clinical Oncology Department
NCT05586659 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-10-19
Summary
Epidemiological Study about behavior of TNBC in Clinical oncology department in 8 y in Asyut university hospital
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2023-11-30
- Completion
- 2023-12-31
More Related Trials
-
Locoregional Recurrence of Breast Cancer
NCT05988112 ·Status: NOT_YET_RECRUITING
-
Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer
NCT06169007 ·Status: NOT_YET_RECRUITING
-
Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer
NCT05914961 ·Status: RECRUITING
-
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer
NCT05358093 ·Status: UNKNOWN
-
Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT04225858 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China
NCT02493569 ·Status: UNKNOWN
-
Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy
NCT05141279 ·Status: UNKNOWN
-
Evaluation of Serum IL-7 as a Biomarker in Breast Cancer
NCT07133685 ·Status: NOT_YET_RECRUITING
-
Role of Sorcin and Annexin A3 in Breast Cancer Patients
NCT03598660 ·Status: UNKNOWN
-
Triple-negative Breast Cancer: a New Perspective on Biomarkers
NCT03539965 ·Status: COMPLETED
-
Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy
NCT05519397 ·Status: COMPLETED
-
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295 ·Status: UNKNOWN
-
Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments
NCT02284581 ·Status: RECRUITING
-
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
NCT01276899 ·Status: COMPLETED
-
Sepsis As a Cause of Death Among Elderly Cancer Patients
NCT06619535 ·Status: COMPLETED
-
An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study
NCT06510127 ·Status: ENROLLING_BY_INVITATION
-
Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome
NCT06261918 ·Status: RECRUITING
-
Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)
NCT02688803 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer
NCT03177902 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
NCT04145947 ·Status: UNKNOWN
-
The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.
NCT03163316 ·Status: COMPLETED
-
BRCA and NACT in TNBC Patients
NCT05750719 ·Status: COMPLETED
-
Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria
NCT02733601 ·Status: COMPLETED
-
Biomarkers in Patients With Metastatic Breast Cancer
NCT05871788 ·Status: NOT_YET_RECRUITING